(IN BRIEF) Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine and Hannover Medical School have developed an innovative cardiac organoid model that simulates a miniature, functional heart to test the cardiotoxicity of new medications. Comprising heart muscle cells, … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged biomedical research, cardiac organoid, cardiotoxicity, drug development, Drug Safety, Fraunhofer, Fraunhofer ITEM, Hannover Medical School, hiPSCs, hypertrophic cardiomyopathy, immune system, induced pluripotent stem cells, macrophages, RNA Therapies
(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk’s acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to EUR 1.025 billion. Based in Hannover, Germany, Cardior specializes in RNA-based therapeutics for cardiovascular diseases, focusing initially on heart failure. … Read the full press release
Posted in Business, Denmark, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Cardior Pharmaceuticals, Christoph Broja, Claudia Ulbrich, Denmark, EQT, EQT Life Sciences, Germany, Heart Diseases, Novo Nordisk, partnership, Professor Thomas Thum, RNA Therapies, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?